🧪
hypothesis

Gamma entrainment suppresses hippocampal ERK1/2 hyperactivity to decrease AD-relevant tau phosphorylation sites

Hypothesis

Gamma entrainment suppresses hippocampal ERK1/2 hyperactivity to decrease AD-relevant tau phosphorylation sites

Excessive ERK1/2 activation in AD hippocampus phosphorylates tau at Ser202/Thr205 (AT8) and Thr231 (AT180) epitopes.
🧬 MAPK3/MAPK1 (ERK1/2); MAP2K1/MAP2K2 (MEK1/2); RASGRF1🩺 alzheimers🎯 Composite 71%💱 $0.64▼22.9%proposed
Alzheimer's disease
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.74 (15%) Evidence 0.72 (15%) Novelty 0.70 (12%) Feasibility 0.65 (12%) Impact 0.78 (12%) Druggability 0.58 (10%) Safety 0.52 (8%) Competition 0.75 (6%) Data Avail. 0.70 (5%) Reproducible 0.68 (5%) KG Connect 0.50 (8%) 0.711 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite71%

🧪 Overview

Excessive ERK1/2 activation in AD hippocampus phosphorylates tau at Ser202/Thr205 (AT8) and Thr231 (AT180) epitopes. Gamma oscillations restore homeostatic calcium signaling, inhibiting Ras-GRF1 and reducing aberrant ERK activity, thereby decreasing toxic tau species. This provides a tau-focused mechanism distinct from the amyloid-centric H1-H3 hypotheses, potentially explaining gamma's effects in tauopathy models. Seizure risk in vulnerable circuits has been raised (Lee 2023), representing a significant safety concern requiring careful dose-response characterization.

🧬 Mechanism

🔗 Mechanism from KG for MAPK3/MAPK1 (ERK1/2); MAP2K1/MAP2K2 (MEK1/2); RASGRF1

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    excitation_inhibition_imb["excitation/inhibition imbalance"] -->|associated with| Early_Alzheimer_S_Disease["Early Alzheimer'S Disease"]
    PV__interneuron_activatio["PV+ interneuron activation"] -->|associated with| excitation_inhibition_bal["excitation/inhibition balance"]
    BDNF["BDNF"] -->|activates| TrkB_receptors["TrkB receptors"]
    PV__interneuron_activatio_1["PV+ interneuron activation"] -->|causes| Memory_Improvements["Memory Improvements"]
    BDNF_2["BDNF"] -->|regulates| gamma_entrainment_memory_["gamma entrainment memory benefits"]
    sess_SRB_2026_04_28_h_bdb["sess_SRB-2026-04-28-h-bdbd2120_task_9aae8fc5"] -->|causal extracted| processed["processed"]
    style excitation_inhibition_imb fill:#4fc3f7,stroke:#333,color:#000
    style Early_Alzheimer_S_Disease fill:#ef5350,stroke:#333,color:#000
    style PV__interneuron_activatio fill:#4fc3f7,stroke:#333,color:#000
    style excitation_inhibition_bal fill:#81c784,stroke:#333,color:#000
    style BDNF fill:#ce93d8,stroke:#333,color:#000
    style TrkB_receptors fill:#4fc3f7,stroke:#333,color:#000
    style PV__interneuron_activatio_1 fill:#4fc3f7,stroke:#333,color:#000
    style Memory_Improvements fill:#4fc3f7,stroke:#333,color:#000
    style BDNF_2 fill:#ce93d8,stroke:#333,color:#000
    style gamma_entrainment_memory_ fill:#4fc3f7,stroke:#333,color:#000
    style sess_SRB_2026_04_28_h_bdb fill:#4fc3f7,stroke:#333,color:#000
    style processed fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
40 Hz reduces p-tau in tauopathy models
PMID:31028117
Supports
MEK-ERK identified as key pathway inhibited by gamma
PMID:37696929
Supports
ERK inhibition prevents gamma-induced seizure risk
PMID:37500625
Contradicts
Seizure promotion risk in vulnerable circuits (Lee 2023) raises safety concerns
PMID:37500625
Contradicts
ERK hyperactivity is upstream of many processes; specificity of gamma's effect is unclear
PMID:37696929
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — MAPK3

No curated PDB or AlphaFold mapping for MAPK3 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for MAPK3 →

No DepMap CRISPR Chronos data found for MAPK3.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Falling
7d Momentum
▼ 1.8%
Volatility
Low
0.0031
Events (7d)
3
Price History
▼22.9%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF 40 Hz gamma entrainment (1 hour/day × 14 days) is applied to rTg4510 tauopathy mice (4.5 months old), THEN soluble AT8-positive tau (Ser202/Thr205) concentration in hippocampal homogenates will decAT8 epitope tau will be reduced by ≥30% in gamma-stimulated rTg4510 mice, with correlated improvement in spatial memory acquisition latency— no observation —pending0.68
IF adult APP/PS1 mice (6-8 months old) receive daily 40 Hz gamma entrainment via visual or auditory stimulation for 7 consecutive days (1 hour/day), THEN hippocampal pERK1/2 (Thr202/Tyr204) levels wilHippocampal pERK1/2 (Thr202/Tyr204) levels will show a statistically significant reduction (p < 0.05) of at least 25% in gamma-entrained mice compared to sham c— no observation —pending0.72
🔮 Falsifiable Predictions (2)
pendingconf 72%
IF adult APP/PS1 mice (6-8 months old) receive daily 40 Hz gamma entrainment via visual or auditory stimulation for 7 consecutive days (1 hour/day), THEN hippocampal pERK1/2 (Thr202/Tyr204) levels will decrease by ≥25% relative to sham-stimulated controls as measured by quantitative western blot wit
Predicted outcome: Hippocampal pERK1/2 (Thr202/Tyr204) levels will show a statistically significant reduction (p < 0.05) of at least 25% in gamma-entrained mice compared
Falsification: No significant reduction or an increase in hippocampal pERK1/2 levels in gamma-entrained mice; pERK1/2 levels remain within 1 SD of sham control values
pendingconf 68%
IF 40 Hz gamma entrainment (1 hour/day × 14 days) is applied to rTg4510 tauopathy mice (4.5 months old), THEN soluble AT8-positive tau (Ser202/Thr205) concentration in hippocampal homogenates will decrease by ≥30% compared to unstimulated rTg4510 controls, AND this will be accompanied by a ≥20% impr
Predicted outcome: AT8 epitope tau will be reduced by ≥30% in gamma-stimulated rTg4510 mice, with correlated improvement in spatial memory acquisition latency
Falsification: AT8 tau levels show no significant change (<10% reduction) or increase following gamma entrainment, OR seizure incidence exceeds 20% in the gamma group requiring termination, indicating loss of therap
View on SciDEX ↗